Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 5
2004 8
2005 10
2006 5
2007 6
2008 9
2009 6
2010 9
2011 10
2012 17
2013 12
2014 14
2015 13
2016 11
2017 7
2018 11
2019 10
2020 7
2021 7
2022 7
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders.
Shiraishi K, Yoshida O, Imai Y, Akbar SMF, Sanada T, Kohara M, Miyazaki T, Kamishita T, Miyake T, Hirooka M, Tokumoto Y, Abe M, Rubido JCA, Nieto GG, Hiasa Y. Shiraishi K, et al. Among authors: miyazaki t. Vaccines (Basel). 2023 Sep 12;11(9):1479. doi: 10.3390/vaccines11091479. Vaccines (Basel). 2023. PMID: 37766155 Free PMC article.
Biodistribution assessment of cationic pullulan nanogel, a nasal vaccine delivery system, in mice and non-human primates.
Yuki Y, Harada N, Sawada SI, Uchida Y, Nakahashi-Ouchida R, Mori H, Yamanoue T, Machita T, Kanazawa M, Fukumoto D, Ohba H, Miyazaki T, Akiyoshi K, Fujihashi K, Kiyono H. Yuki Y, et al. Among authors: miyazaki t. Vaccine. 2023 Jul 31;41(34):4941-4949. doi: 10.1016/j.vaccine.2023.06.065. Epub 2023 Jun 27. Vaccine. 2023. PMID: 37385890 Free article.
Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with chronic hepatitis B; 18 months follow-up results of phase IIa clinical study.
Yoshida O, Akbar SMF, Imai Y, Sanada T, Tsukiyama-Kohara K, Miyazaki T, Kamishita T, Miyake T, Tokumoto Y, Hikita H, Tsuge M, Shimizu M, Al Mahtab M, Aguilar JC, Guillen G, Kohara M, Hiasa Y. Yoshida O, et al. Among authors: miyazaki t. Hepatol Res. 2023 Mar;53(3):196-207. doi: 10.1111/hepr.13851. Epub 2022 Nov 18. Hepatol Res. 2023. PMID: 36399406
Validation of the obesity paradox by body mass index and waist circumference in patients undergoing percutaneous coronary intervention.
Shirahama Y, Tabata N, Sakamoto K, Sato R, Yamanaga K, Fujisue K, Sueta D, Araki S, Takashio S, Arima Y, Hokimoto S, Sato K, Sakamoto T, Nakao K, Shimomura H, Matsumura T, Tayama S, Fujimoto K, Oshima S, Nakamura S, Tsunoda R, Hirose T, Kikuta K, Sakaino N, Yamamoto N, Kajiwara I, Suzuki S, Yamamoto E, Kaikita K, Matsushita K, Tsujita K; Kumamoto Intervention Conference Study (KICS) Investigators. Shirahama Y, et al. Int J Obes (Lond). 2022 Oct;46(10):1840-1848. doi: 10.1038/s41366-022-01163-7. Epub 2022 Jul 28. Int J Obes (Lond). 2022. PMID: 35902692
171 results